Tim Clackson
Ariadne Diagnostics (United States)(US)Xilio Therapeutics (United States)(US)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations, PI3K/AKT/mTOR signaling in cancer, Virus-based gene therapy research
Most-Cited Works
- → A Hot Spot of Binding Energy in a Hormone-Receptor Interface(1995)1,991 cited
- → AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance(2009)1,234 cited
- → Making antibody fragments using phage display libraries(1991)1,207 cited
- → A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias(2013)1,111 cited
- → Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias(2012)762 cited
- → Redesigning an FKBP–ligand interface to generate chemical dimerizers with novel specificity(1998)559 cited